Cargando…
Fenofibrate improves vascular endothelial function and contractility in diabetic mice
Fenofibrate, a peroxisome proliferator-activated receptors α (PPARα) agonist, reduces vascular complications of diabetic patients but its protective mechanisms are not fully understood. Here we tested the hypothesis that fenofibrate improves vascular endothelial dysfunction by balancing endothelium-...
Autores principales: | Xu, Nan, Wang, Qin, Jiang, Shan, Wang, Qijing, Hu, Weipeng, Zhou, Suhan, Zhao, Liang, Xie, Lanyu, Chen, Jianghua, Wellstein, Anton, Lai, En Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174921/ https://www.ncbi.nlm.nih.gov/pubmed/30296701 http://dx.doi.org/10.1016/j.redox.2018.09.024 |
Ejemplares similares
-
Therapeutic Effects of Fenofibrate on Diabetic Peripheral Neuropathy by Improving Endothelial and Neural Survival in db/db Mice
por: Cho, Ye Rim, et al.
Publicado: (2014) -
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013) -
Increased Vascular Contractility in Hypertension Results From Impaired Endothelial Calcium Signaling
por: Wilson, Calum, et al.
Publicado: (2019) -
Protective Effect of Fenofibrate on Oxidative Stress-Induced Apoptosis in Retinal–Choroidal Vascular Endothelial Cells: Implication for Diabetic Retinopathy Treatment
por: Hsu, Ying-Jung, et al.
Publicado: (2020) -
Enhanced Renal Afferent Arteriolar Reactive Oxygen Species and Contractility to Endothelin-1 Are Associated with Canonical Wnt Signaling in Diabetic Mice
por: Zhang, Suping, et al.
Publicado: (2018)